Vaccine group Gavi seeks to broaden donor base as aid budgets shrink
RABAT - Global vaccine group Gavi is seeking new donors for its work funding childhood immunisation in the world's poorest countries, its chief executive told Reuters, as many traditional funders cut international aid budgets.
Gavi is aiming to raise $9 billion at a summit in Brussels later this month for its work from 2026-2030, but countries including the United States, the United Kingdom and France have all signalled that they plan to slash global aid funding in the coming years, and their pledges remain uncertain.
"We want to broaden our donor base," Gavi's Sania Nishtar told Reuters in Rabat, where she met officials to encourage Morocco to join as a new donor.
She said that India and Indonesia, which had previously been supported by Gavi, were now contributing as donors to the organization, which works with low and middle-income countries to buy vaccines for diseases from measles to cholera.
Other countries like Portugal have also increased their funding commitment, she said.
During her Morocco visit, Nishtar toured a vaccine manufacturing facility near Casablanca under development by Marbio, a biopharmaceutical venture backed by Morocco.
She said the plant had "a good chance" of benefiting from Gavi's $1.2 billion African Vaccine Manufacturing Accelerator, a scheme aimed at boosting vaccine production on the continent.
Gavi has already sought out more private sector donors, initiated cost-saving initiatives, and discussed closer collaboration with other global health groups as part of plans to try to tackle potential shortfalls in funding.
Nishtar said the organization was making contingency plans, but she hoped that donors at the June 25 summit would give enough that they would not be needed.
A U.S. government document showed in March that the U.S., which has previously given around $300 million to Gavi annually, did not plan any future funding.
Nishtar said that Gavi has not yet received this year's funding, which has already been approved by Congress.
Gavi is currently focused on combating a global measles outbreak and is responding to cholera outbreaks in Sudan, South Sudan, and Angola, where it has made special arrangements to supply vaccines from its stockpiles, Nishtar said.
It is also supporting Sierra Leone, where the spread of mpox has accelerated. REUTERS
Join ST's Telegram channel and get the latest breaking news delivered to you.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
13 hours ago
- Straits Times
Kennedy's ouster of US vaccine advisers puts pharma ties under scrutiny
FILE PHOTO: U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. testifies before a Senate Health, Education, Labor & Pensions Committee hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 14, 2025. REUTERS/Leah Millis/File Photo U.S. Health Secretary Robert F. Kennedy Jr.'s surprise ouster of a national vaccine advisory board, claiming it was "plagued with persistent conflicts of interest," puts new scrutiny on the group that recommends which shots should be administered to the American public. Kennedy said most vaccine experts on the 17-member Advisory Committee on Immunization Practices (ACIP) have received "substantial funding" from drugmakers. He did not provide examples of conflicts of interest for any individual adviser or say how that may have influenced specific recommendations. Committee members say their work with the U.S. Centers for Disease Control and Prevention follows rigorous vetting of their financial ties. They must abstain from votes on any vaccine for which they have a conflict, as well as any rival to that vaccine or any product from the same manufacturer, according to CDC rules. The agency's website lists one of the departing panel members as recusing herself over such conflicts. "To determine that the whole (advisory board), all 17 members, have conflicts of interest, that has not been shown by the evidence," fired board member Dr. Oliver Brooks told Reuters. "However, the decisions that have been made (by Kennedy) undermine confidence in the process and in vaccines." Six of the vaccine advisers fired by Kennedy received a total of $80 or less from drugmakers from 2017 to 2023, according to a Reuters review of the Open Payments federal database of industry payments to healthcare providers. Seven other panel members received between $4,000 and $55,000 from drugmakers for consulting, speaking fees, travel or meals over the period 2017 to 2023. Two of those experts had also worked with other scientists in industry-funded research projects worth several millions of dollars. Brooks, retired chief medical officer at Watts Healthcare in Los Angeles and former president of the National Medical Association, received nearly $44,000 in general payments from Sanofi, according to the government records. Most of the payments occurred in 2017 and 2018, with nothing after 2020. Brooks became a vaccine adviser in 2021, and did not disclose any conflicts that would preclude him from voting. He said the panel's sole aim is "to prevent vaccine-preventable illness." Sanofi declined to comment. At least three vaccine advisers were not health professionals tracked by mandatory Open Payments reporting. KENNEDY'S CONFLICT Kennedy, who has spent years sowing doubts about vaccine safety and efficacy contrary to scientific evidence, faced questions from Congress about his own potential conflicts of interest during a confirmation hearing. Kennedy said he would divest his financial interest in litigation against Merck over its Gardasil vaccine, which prevents cancers caused by the human papillomavirus, to his non-dependent, adult son. In posts on X this week, Kennedy said he would share "examples of the historical corruption at ACIP" and announced eight new panel members. Four of them had received nominal reimbursement for meals, according to Open Payments, while the remainder recorded no payments or weren't covered by the database. A 2009 federal inspector general's report criticized the CDC for lax enforcement of disclosures among its advisory panels. New research shared with Reuters suggests conflicts have since declined among vaccine board members. "People are more aware of these issues on advisory committees, so they're facing greater scrutiny there," said Dr. Genevieve Kanter, an associate professor of public policy at the University of Southern California who has studied conflicts among government health advisers. Kanter's analysis of vaccine panel disclosures found that, on average, 43% of panel members facing decisions on specific vaccines declared conflicts in 2000 compared to 5%, on average, at meetings over the last 10 years. Kanter said it will also be important to understand how the vaccine advisers assembled by Kennedy are vetted for conflicts. They are due to meet at the end of June. "We don't want to replace one conflict with another set of conflicts," she said. "If someone has a financial interest in treatments that are believed to be alternatives to vaccines for certain conditions, we want to know that." DISCLOSURE RULES ACIP members are required to divest all stock in vaccine makers and stop any active consulting work for those companies before joining the panel. They can't accept travel or food from vaccine companies or collect product royalties. Similar restrictions apply to family members. Committee members can keep working on vaccine clinical trials funded by industry and those research grants can help cover their salaries. They are required to file annual disclosures and recuse themselves from votes when specific conflicts arise. "ACIP members ... are carefully screened for major conflicts of interest and selected through a lengthy process," said the California Department of Public Health, whose immunization chief, Dr. Robert Schechter, was fired from the panel by Kennedy. One of the fired panel members, Dr. Bonnie Maldonado, is a pediatric infectious diseases specialist at Stanford University who has led vaccine studies worldwide. She participated in research that received $4.65 million in funding from Pfizer, most of it spanning 2021 to 2023. The studies involved vaccines for COVID-19, RSV and other diseases. Maldonado also received general payments from drugmakers, including $26,465 from Pfizer and nearly $7,000 from Merck. Maldonado abstained from a vote on COVID vaccine recommendations in June 2024, declaring a conflict of interest. In October, she did participate in a COVID-related vote. Maldonado didn't respond to a request for comment. Noel Brewer, a professor of public health at the University of North Carolina, is not a clinician and therefore not included in Open Payments. In a 2017 research paper, he disclosed receiving research grants from Merck, Pfizer and GSK and serving on a paid advisory board for Merck. The disclosures did not give details on the payment amounts. Spokespeople for the three vaccine makers were not immediately available for comment. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
14 hours ago
- Straits Times
Thai panel upholds suspension of doctors who helped ex-PM Thaksin dodge jail
FILE PHOTO: Former Thai Prime Minister Thaksin Shinawatra speaks with businessmen ahead of the \"Vision for Thailand\" event in Bangkok, Thailand, August 22, 2024. Picture taken through glass. REUTERS/Athit Perawongmetha/File Photo BANGKOK - Thailand's medical council on Thursday upheld its suspension of two doctors who enabled influential politician Thaksin Shinawatra to spend his prison sentence in hospital, a day ahead of the start of a Supreme Court case that could see him jailed. Thaksin, the driving force behind the current government, returned from 15 years of self-exile in 2023 to serve a prison term for abuse of power and conflicts of interest, but was sent to hospital after only a few hours in jail complaining of chest problems. The polarising billionaire, whose daughter Paetongtarn Shinawatra is prime minister, stayed in a VIP wing of the hospital for six months until his release on parole without a single night in jail, prompting public outrage and deep scepticism about the extent of his ailments. "More than two-thirds of the council voted to uphold the punishments," Medical Council of Thailand vice president, Prasit Watanapa, told reporters. "Members made the decision based on medical principles, evidence and reason." The suspensions could impact a case at the Supreme Court that begins on Friday in which the legality of Thaksin's hospital stay has been challenged, with the possibility the tycoon could be made to serve that time again, in prison. Thaksin, 75, remains a towering figure in Thai politics and though he holds no formal government role, he is highly influential. His lawyer declined to comment on Thursday on the council's decision. The revival of the controversy over Thaksin's hospital stay comes at a challenging time for Paetongtarn's government, which is seeing its popularity dwindle amid a prolonged struggle to spur economic growth and domestic pressure to take a tougher stance on an ongoing border dispute with Cambodia. Thaksin's sentence was originally eight years, but it was commuted to a year by the king and he became eligible for parole after six months. The medical council's vote overrides a veto of its earlier decision by Health Minister Somsak Thapsutin, a Thaksin ally. The council had yet to confirm the duration of the suspension of the two doctors, who it found had issued documents that contained false medical information. They had denied wrongdoing and stood by their medical assessments. Another doctor with the corrections department received a warning for failing to meet medical standards in a referral notice for Thaksin. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Straits Times
21 hours ago
- Straits Times
Vaccine demand in Malaysia rises amid regional surge in Covid-19 cases
The revived interest is given the rising numbers of the new variant of Covid-19 in Thailand and Singapore. PHOTO: REUTERS GEORGE TOWN, Malaysia - Medical practitioners are seeing a renewed interest in vaccination and booster shots, particularly among vulnerable populations, amid a concerning surge in Covid-19 cases in neighbouring countries. General practitioner Dr Parmjit Singh said the revived interest is in response to locals being highly vigilant given the rising numbers of the new variant of Covid-19 in Thailand and Singapore. 'It is essential for eligible individuals to be up to date with their vaccinations to maintain strong protection, especially against emerging variants,' he said here on June 11. He also said that while the Covid-19 situation in the country may appear stable, it has not been eradicated. 'Malaysians are encouraged to stay up to date with vaccinations, practise good hygiene, wear masks in crowded or enclosed spaces and seek medical attention if symptoms develop. 'Continued public awareness and responsible behaviour are key to preventing another surge in cases. 'New variants may spread across borders through travel and community interactions,' he said. Dr Parmjit also said that there is no definitive evidence that dry weather can cause a spike in Covid-19 cases. 'Weather changes can influence human behaviour. People may spend more time indoors in air-conditioned spaces during hot, dry seasons, which could increase the risk of virus transmission. 'The spread of the virus is dependent on factors such as population density, vaccination coverage, public health measures and individual behaviour,' he said. Penang health committee chairman Daniel Gooi said Penang experienced notable spikes during major holidays or festive periods due to increased travel, relaxed precautions and social gatherings. 'While there is no evidence that dry weather increases Covid-19 transmission, in Malaysia, hot and dry conditions may lead to more indoor gatherings. This could facilitate virus spread,' he said. It was reported that neighbouring countries like Thailand and Singapore are facing an emergence of subvariants derived from the Omicron strain of Covid-19, which are more contagious, leading to a surge in cases. Mr Gooi said while cases have dropped in Penang, it is important to remain vigilant as records from Jan 1 to May 31 last year showed 2,714 cases, while 1,594 cases were recorded during the same period this year. 'No deaths have been recorded so far this year, and the state Health Department continues to monitor respiratory-related clusters in Penang. 'High-risk groups (the elderly and persons with chronic illnesses) are advised to avoid crowded indoor areas. 'The vulnerable groups (elderly, comorbidities) are still encouraged to get updated boosters as they can help protect them in case of exposure to those with Covid-19,' he said. Retired teacher B. Premala, 68, who has been vaccinated and took one booster jab in 2021 as well, said she was not keen on taking a fourth jab. 'I am careful and mask up when I go to crowded places. 'I am aware that because of my age, I am susceptible to viruses, but I am cautious,' she said. THE STAR/ ASIA NEWS NETWORK Join ST's Telegram channel and get the latest breaking news delivered to you.
